Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

Dr Annalisa Morgan reflects on incorporating new treatments discussed at the 2025 ACTRIMS Forum into clinical practice.

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

Type 1, not type 2 diabetes, is autoimmune. There are other rarer autoimmune types. Learn about type 2 diabetes, immunity, ...

Or, MD, a distinguished researcher and neurologist at Penn Medicine, is the winner of the 2025 John Dystel Prize for Multiple ...

New therapeutic "cocktails" could offer long-lasting relief for treatment-resistant asthma and other inflammatory diseases of ...

A four-month-old baby diagnosed with a rare blood disorder has found a donor and had a stem cell transplant that could save her life. Dolcie-Mae Edwards-Raymond, from Newport, has hemophagocytic ...

"The City did not initiate moving the cell tower. The City agreed to this to accommodate the State’s intended use of the land ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

A mum whose friend's death from leukaemia prompted her to bank stem cells from her newborn's umbilical cord has described it ...

Study finds antibodies that target Epstein-Barr virus proteins can also attack proteins in the brain, increasing the likelihood of MS.

A screen of human-infecting viruses identified extensive examples of viral proteins that resembled human sequences, which ...